CIP
NUVA

Champlain Investment Partners’s NuVasive, Inc. NUVA Stock Holding History

Champlain Investment Partners’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-400,840
Closed -$31M – 128
2019
Q4 		$31M Sell
400,840
-541,240
-57% -$38.2M 0.23% 107
2019
Q3 		$59.7M Sell
942,080
-577,490
-38% -$36.1M 0.49% 82
2019
Q2 		$89M Sell
1,519,570
-755,570
-33% -$44.6M 0.75% 63
2019
Q1 		$129M Sell
2,275,140
-264,990
-10% -$14.1M 1.13% 35
2018
Q4 		$126M Sell
2,540,130
-617,075
-20% -$37.1M 1.28% 22
2018
Q3 		$224M Buy
3,157,205
+2,315
+0.1% +$147K 1.99% 4
2018
Q2 		$164M Buy
3,154,890
+14,780
+0.5% +$774K 1.59% 11
2018
Q1 		$164M Buy
3,140,110
+273,863
+10% +$13.9M 1.77% 5
2017
Q4 		$168M Buy
2,866,247
+171,455
+6% +$9.72M 1.9% 7
2017
Q3 		$149M Buy
2,694,792
+500,907
+23% +$33.1M 1.76% 9
2017
Q2 		$169M Buy
2,193,885
+285,605
+15% +$21.3M 2.06% 8
2017
Q1 		$143M Buy
1,908,280
+42,395
+2% +$3.08M 1.87% 8
2016
Q4 		$126M Buy
1,865,885
+127,480
+7% +$8.22M 1.74% 10
2016
Q3 		$116M Buy
1,738,405
+55,575
+3% +$3.54M 1.76% 10
2016
Q2 		$100M Buy
1,682,830
+625,555
+59% +$33.8M 1.73% 10
2016
Q1 		$51.4M Sell
1,057,275
-100,320
-9% -$4.55M 0.93% 36
2015
Q4 		$62.6M Buy
1,157,595
+48,649
+4% +$2.48M 1.07% 26
2015
Q3 		$53.5M Sell
1,108,946
-19,664
-2% -$1.02M 0.93% 40
2015
Q2 		$53.5M Sell
1,128,610
-257,520
-19% -$12M 0.84% 47
2015
Q1 		$63.7M Sell
1,386,130
-400,600
-22% -$18.6M 1.09% 29
2014
Q4 		$84.3M Sell
1,786,730
-30,630
-2% -$1.28M 1.34% 16
2014
Q3 		$63.4M Sell
1,817,360
-37,380
-2% -$1.33M 1.1% 25
2014
Q2 		$66M Buy
1,854,740
+18,590
+1% +$636K 1.08% 21
2014
Q1 		$70.5M Sell
1,836,150
-38,045
-2% -$1.4M 1.21% 18
2013
Q4 		$60.6M Sell
1,874,195
-45,185
-2% -$1.36M 1.07% 26
2013
Q3 		$47M Sell
1,919,380
-1,130
-0.1% -$27.8K 0.89% 43
2013
Q2 		$47.6M Buy
+1,920,510
New +$42M 0.96% 36

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Champlain Investment Partners's NUVA Position: Q1 2020 in Review

Champlain Investment Partners sold out of NuVasive, Inc. (NUVA) in Q1 2020, closing a stake of 400,840 shares — an estimated $31M sold.

Champlain Investment Partners first reported a position in NUVA in Q2 2013 and held it in 27 quarters. The position peaked at $224M in Q3 2018. 266 funds tracked by Wall St. Rank hold NUVA as of Q1 2020.

  • Champlain Investment Partners reported no remaining NuVasive, Inc. position as of Q1 2020 after selling out during the quarter.
  • Champlain Investment Partners sold 400,840 NuVasive, Inc. shares in Q1 2020, an estimated $31M.
  • Champlain Investment Partners first reported a position in NuVasive, Inc. in Q2 2013 and held it in 27 quarters.
  • Champlain Investment Partners's NuVasive, Inc. position peaked at $224M in Q3 2018.
  • 266 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2020.

Based on Champlain Investment Partners's 13F filing for Q1 2020, filed 14 May 2020.